Home > Insider Trading > Filing (0001179110-21-005054)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1477449	Teladoc Health Inc.	TDOC	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1208500	N Jason Gorevic	C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-02	23,067	$1.67	694,350	No	4	M	Direct
Common Stock	Acquisiton	2020-06-02	1,933	$6.01	696,283	No	4	M	Direct
Common Stock	Disposition	2020-06-02	1,600	$165.60	694,683	No	4	S	Direct
Common Stock	Disposition	2020-06-02	3,899	$166.73	690,784	No	4	S	Direct
Common Stock	Disposition	2020-06-02	4,916	$167.70	685,868	No	4	S	Direct
Common Stock	Disposition	2020-06-02	5,791	$168.80	680,077	No	4	S	Direct
Common Stock	Disposition	2020-06-02	7,794	$169.66	672,283	No	4	S	Direct
Common Stock	Disposition	2020-06-02	600	$170.41	671,683	No	4	S	Direct
Common Stock	Disposition	2020-06-02	100	$171.32	671,583	No	4	S	Direct
Common Stock	Disposition	2020-06-02	300	$172.58	671,283	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-06-02	23,067	$0.00	23,067	$1.67
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-06-02	1,933	$0.00	1,933	$6.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-12-11	No	4	M	Direct
120,310		2024-12-22	No	4	M	Direct

Footnotes

The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.
Represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4.
Represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive.
Represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive.
Represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive.
Represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive.
Represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive.
The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.
The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.